The Fly

Pfizer to invest over $2.5B at Belgium, Ireland plants, Reuters reports

Pfizer plans to invest more than $2.5B to expand its drug manufacturing sites in Puurs, Belgium, and Dublin, Ireland, Reuters’ Michael Erman reports. "It is all aligned with the growth of our pipeline," Pfizer Chief Global Supply Officer Mike McDermott told Reuters. Pfizer hopes to introduce as many as 19 new medicines over the next year and a half, including treatments for ulcerative colitis and migraines, as well as its vaccine for RSV, the report notes. Reference Link

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on PFE:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More